mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.001 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |